Articles

Browse our regulatory articles below or search through our archive.

 


 

THE GCC HEALTHCARE MARKET SERIES: KUWAIT

by Arazy Group | Sep 01, 2016
 
An introduction to Kuwait
 
Kuwait, one of the world's richest countries per capita, is in the northwestern corner of the Persian Gulf, nestled between Iraq and Saudi Arabia. Spanning over 17,000 square kilometers, the country was home to a population of 3,892,000 in 2015. Statistics shared by National Geographic show that one third of the population is made up of Kuwaiti Arabs, while Egyptian and Palestinian Arabs make up 22% and non-Arabs (mostly South Asians) make up 38 %.
 
According to The World Factbook by the Central Intelligence Agency, Kuwait has crude oil reserves of approximately 102 billion barrels - more than 6% of world reserves -and Kuwaiti officials plan to increase oil production to 4 million barrels per day by 2020. It also states that petroleum accounts for over half of Gross Domestic Product (GDP), 94% of export revenues and 90% of government income.

Healthcare expenditure in Kuwait
 
Kuwait is home to one of the more advanced and modern healthcare systems that can be found in the Middle East. Statistics released by the World Health Organization (WHO) showed that in 2014 total expenditure on health per capita was $ 2,320, while total expenditure on health was 3% of GDP. In September 2015 market research store Research and Markets, reported that private healthcare accounted for around a fifth of total spending and that the Kuwaiti government was funding treatment for many nationals abroad at the time.
 
According to Research and Markets, as the country’s population expands and grows older and the prevalence of non-communicable diseases (such as diabetes and obesity increases), the government is coming under increasing pressure to improve its domestic facilities. The government embarked on a US$108bn project to provide an additional 3,500 hospital beds and boost healthcare facilities. It estimated that once the project was completed, an additional 15,000 healthcare professionals would be required.
 
Kuwait’s healthcare market predicted to grow

 
With many Kuwaitis continuing to seek treatment abroad, the cost of providing healthcare is set to rise substantially in the coming years, according to the Oxford Business Group’s Kuwait 2015 report. Alpen Capital, a financial advisory services provider operating across the GCC and South Asia, said it expected the Kuwait healthcare market to grow at a compound annual growth rate (CAGR) of 9.4% between 2013 and 2018, increasing the total value of the market from $3.5bn to $5.4bn. In 2018, the outpatient market is forecast to be worth around $3.9bn, or 72%, while the size of the inpatient market is forecast to be worth $1.5bn, or 28%.
 
Regulation of Kuwaiti healthcare

 
Kuwait’s Ministry of Health (MoH) is ultimately responsible for the various aspects of the healthcare system, including public health. preventative health and the regulating of the private sector.  While this is the case, other public or semi-public institutions, such as the military, operate autonomous healthcare systems for their own employees.
 
Some organizations pay for private health insurance for their employees, and as private provision increases, the government continues to assess the possibility of creating an independent healthcare regulator, to assume policy licensing and quality assurance functions.
 
 
Private sector healthcare
 
While the country’s government remains the main provider of healthcare, several private healthcare groups and hospitals are currently in operation. Al Salam International Hospital, New Mowasat Hospital and Royale Hayat Hospital are three of the most prominent providers of private healthcare.
 
Situated in Dasma, Al Salam International Hospital serves the private Kuwaiti and expatriate market on both an outpatient and an inpatient basis. It provides specialized medical care in obstetric gynecology, surgical, medical, pediatric and critical care services and offers a variety of specialized clinic services designed to meet the particular needs of the population, such as dental services, dialysis and maternal-child healthcare.
 
Nearby Salmiya is home to New Mowasat Hospital, a 100-bed facility that spans 27,000 square meters and is owned by Mowasat Healthcare Company (MHC), a publicly traded company on the Kuwait Stock Exchange. It offers services in various branches of medicine including gynecology, ophthalmology, neurosurgery, cardiology and urology. The hospital has received accreditation from healthcare bodies Accreditation Canada International (ACI) and Joint Commission International, as well as been voted a “Superbrand” by the Superbrands Council, which selects the top brands under various categories.
 
Royale Hayat Hospital in Jabriya is also a multi-specialty healthcare provider, which was originally a hospital serving only women and children.  In February 2016, Royale Hayat was voted Kuwait’s best hospital for the 6th consecutive year in the Service Hero Awards, Arab World's only 100% consumer-driven customer satisfaction index. 
 
Medical and IVD Devices
 

Kuwait is completely dependent on imports for medical devices, which has created significant advantages for US suppliers, including competitive pricing. Today, European suppliers are increasingly gaining market share as a result of their close proximity to the market and perceived high level of customer support.
 
Medical and in vitro diagnostic (IVD) devices in Kuwait are regulated by the Ministry of Health’s Department for Unclassified and Medical Devices. The country’s classification system follows the EU model of risk-based Classes I, IIa, IIb and III, and an authorized representative is required to register products there. 
 
Contact us today to discover how LICENSALE.COM® assists MedTech companies in gaining access to the Kuwait medical devices market and 100+ others faster and more cost-effectively than ever before. 

 
 
 
 
 
 
 
Category:
  • Blog
Tags:
latest news
  • Apr 24 2017
    70+ CLASS I DEVICES NOW EXEMPT FROM 510(K) REQUIREMENTS

    The US Food and Drug Administration (FDA) has identified a list of over 70 class I devices that are now exempt from premarket notification requirements....

    Read More
  • Apr 19 2017
    REGULATORY UPDATE: ETGAR MEDICAL INSTRUMENTS

    USA: Etgar Medical Instruments' Dental Implants System was approved for sale with LICENSALE.COM®. ...

    Read More
  • Apr 19 2017
    RUSSIAN REGULATORS ISSUE REQUIREMENTS FOR IVD & MEDICAL DEVICE TECHNICAL FILE SUBMISSIONS

    The Russian Ministry of Health has introduced a new regulation that clarifies the official requirements for in vitro diagnostic (IVD) & medical device technical file submissions. ...

    Read More
  • Apr 6 2017
    REMINDER: ARAZY GROUP CAN HELP REGISTER MEDICAL DEVICES IN BRAZIL IN JUST 7-9 MONTHS

    As a member of ABIMED (the Brazilian Association of Industry of High Technology Medical and Hospital Equipments, Products and Suppliers), Arazy Group can help medical device manufacturers register their products in Brazil within seven to nine months. ...

    Read More
  • Apr 4 2017
    ARAZY GROUP OFFERS QMS UPGRADE TO ISO 13485:2016 STANDARD

    In line with its commitment to making safe and effective IVD and medical devices available worldwide, regulatory affairs firm Arazy Group Consultants Inc. is assisting MedTech manufacturers in meeting the deadline to upgrade their quality management syste...

    Read More

VANCOUVER OFFICE

  • Phone +1 604.681.6888
  • Fax +1 604.681.6822
  • info@arazygroup.com
  •  
  • #350-1333 Johnston Street
  • Pier 32, Granville Island
  • Vancouver, British Columbia
  • Canada V6H 3R9

BACK TO TOP